​

MDxHealth (MDXH) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

MDXH Stock Forecast

MDxHealth (MDXH) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $4.00 and a low of $4.00. This represents a 627.27% increase from the last price of $0.55.

High: $4 Avg: $4 Low: $4 Last Closed Price: $0.55

MDXH Stock Rating

MDxHealth stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

MDXH Price Target Upside V Benchmarks

TypeNameUpside
StockMDxHealth627.27%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks18.82%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$4.00$4.00$4.00
Last Closing Price$0.55$0.55$0.55
Upside/Downside627.27%627.27%627.27%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-51--6
May, 26-6---6
Apr, 26-6---6
Mar, 26-6---6
Feb, 26-6---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 14, 2026BTIG$4.00$1.95105.13%627.27%
Aug 26, 2022Mark MassaroBTIG$15.00$8.1983.15%2627.27%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 14, 2026William BlairOutperformMarket Performdowngrade
May 14, 2026Cowen & Co.BuyBuyhold
Oct 31, 2024Lake StreetBuyinitialise
Mar 07, 2024BTIGBuyBuyhold
May 31, 2023Noble CapitalOutperforminitialise
May 16, 2023BTIGBuyBuyhold
Aug 26, 2022BTIGBuyBuyhold
Apr 26, 2022Zacks Investment ResearchSelldowngrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-2.53$-3.16$-1.66----
Avg Forecast$-2.16$-2.37$-1.27$-1.20$-0.54$-0.30$0.21
High Forecast$-2.12$-2.29$-1.23$-1.15$-0.47$-0.29$0.21
Low Forecast$-2.22$-2.41$-1.31$-1.25$-0.66$-0.30$0.20
Surprise %17.13%33.33%30.71%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$22.24M$37.05M$70.19M----
Avg Forecast$22.90M$36.93M$69.36M$88.62M$106.20M$120.48M$142.70M
High Forecast$23.36M$37.40M$70.30M$88.70M$107.64M$122.12M$144.64M
Low Forecast$22.59M$35.91M$67.84M$88.53M$103.88M$117.86M$139.59M
Surprise %-2.91%0.33%1.21%----

Net Income Forecast

$-65M $-50M $-35M $-20M $-5M $10M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-30.88M$-50.19M$-43.10M----
Avg Forecast$-55.97M$-61.47M$-33.01M$-31.18M$-14.04M$-7.71M$5.44M
High Forecast$-54.96M$-59.27M$-31.74M$-29.82M$-12.19M$-7.49M$5.54M
Low Forecast$-57.41M$-62.49M$-33.86M$-32.26M$-17.03M$-7.84M$5.29M
Surprise %-44.83%-18.36%30.55%----

MDXH Forecast FAQ

Is MDxHealth stock a buy?

MDxHealth stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MDxHealth is a favorable investment for most analysts.

What is MDxHealth's price target?

MDxHealth's price target, set by 6 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $4 at the low end to $4 at the high end, suggesting a potential 627.27% change from the previous closing price of $0.55.

How does MDxHealth stock forecast compare to its benchmarks?

MDxHealth's stock forecast shows a 627.27% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (18.82%).

What is the breakdown of analyst ratings for MDxHealth over the past three months?

  • June 2026: 0% Strong Buy, 83.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is MDxHealth’s EPS forecast?

MDxHealth's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.2, marking a -27.71% decrease from the reported $-1.66 in 2023. Estimates for the following years are $-0.54 in 2025, $-0.3 in 2026, and $0.21 in 2027.

What is MDxHealth’s revenue forecast?

MDxHealth's average annual revenue forecast for its fiscal year ending in December 2024 is $88.62M, reflecting a 26.25% increase from the reported $70.19M in 2023. The forecast for 2025 is $106.2M, followed by $120.48M for 2026, and $142.7M for 2027.

What is MDxHealth’s net income forecast?

MDxHealth's net income forecast for the fiscal year ending in December 2024 stands at $-31.179M, representing a -27.66% decrease from the reported $-43.1M in 2023. Projections indicate $-14.035M in 2025, $-7.708M in 2026, and $5.44M in 2027.